Abstract:e23515 Background: Osteosarcoma is a kind of primary bone malignancies with high invasiveness and poor prognosis. However, effective therapy for osteosarcoma is still lacking. In fact, the advancement of clinical practice and innovative therapy was hindered by the limited understanding of the genetic characteristics and the mechanism of metastasis. Exploration of the mutational and evolutionary features of osteosarcoma is warranted. Methods: A total of 24 samples of matched primary and metastatic lesions were collected from 12 osteosarcoma patients. Targeted sequencing including 672 cancer-related genes was conducted in 9 patients while whole exome sequencing was performed in 3 patients. Results: High-frequency mutation genes were TP53 (42%), FLCN (33%), GID4 (33%), ATRX (25%), CCND3 (25%) in primary osteosarcoma, comparing to FLCN (42%), GID4 (42%), CCNE1 (25%), MYO15A (25%), ATRX (25%) in metastatic lesion. The PI3K-Akt and MAPK signaling pathway was significantly enriched in both primary (PI3K, p < 0.001; MAPK, p < 0.001) and metastatic lesions. (PI3K, p < 0.001; MAPK, p < 0.001), Additionally, chromosome region 17p11.2, including the driver genes NCOR1, MAP2K4, ALOX12B, AURKB, CDK12, was significantly amplified in primary (G-score = 1.9, q-value = 0.06) and metastatic lesions (G-score = 3.2, q-value < 0.001). These data suggested that changes of PI3K and MAPK pathways and amplification of region 17p11.2 may contribute to initial osteosarcoma tumorigenesis and possibly early metastasis. In contrast, the FoxO, mTOR and HIF-1 signaling pathway were only enriched in metastatic lesions (FOXO, p < 0.001; mTOR, p < 0.05; HIF-1, p < 0.001), implying that these pathways may be critical for osteosarcoma metastatic occurrence. Finally, clonality analysis showed that cellular clonal prevalence (CCF) of subclones including diver genes of ATRX, MYO15A and MYB, were increased ( ATRX: P, CCF = 0.59, M, CCF = 0.74; MYO15A: P, CCF = 0.43, M, CCF = 0.52; MYB: P, CCF = 0.11, M, CCF = 0.52) in metastatic lesions, which further confirmed that alterations of ATRX and MYO15A were considerably vital for osteosarcoma. Conclusions: The abnormal changes of PI3K-Akt and MAPK signaling pathway as well as the amplification of 17p11.2 chromosome region may contribute to osteosarcoma tumorigenesis and possibly early metastasis; whereas pathways of FoxO, mTOR, HIF-1 and driver genes including ATRX, MYO15A and MYB, may play a key role in the metastasis of osteosarcoma.

HER4 Promotes the Growth and Metastasis of Osteosarcoma Via the PI3K/AKT Pathway.

HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway

Prognostic Significance of the Expression of HER Family Members in Primary Osteosarcoma

HER4 Promotes Cell Survival and Chemoresistance in Osteosarcoma Via Interaction with NDRG1.

Over-expression of HER 2 promotes cell metastasis and is associated with the prognosis of osteosarcoma

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Hypoxia-inducible Factor-1 Promotes Cancer Progression Through Activating AKT/Cyclin D1 Signaling Pathway in Osteosarcoma

PI3K/Akt signaling in osteosarcoma

HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies

Chondroitin Polymerizing Factor (CHPF) Promotes Cell Proliferation and Tumor Growth in Human Osteosarcoma by Inhibiting SKP2's Ubiquitination While Activating the AKT Pathway

MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma

URG4 Mediates Cell Proliferation and Cell Cycle in Osteosarcoma Via GSK3β/β-catenin/cyclin D1 Signaling Pathway

Prognostic significance of HER2 expression in osteosarcoma

HER2 Expression is Correlated with Increased Risk of Lung Metastasis in Osteosarcoma

P4HA2 Promotes Proliferation, Invasion, and Metastasis Through Regulation of the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.

Expression of HER—2 in Human Osteosarcoma

Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma.

KLF4 Functions As an Oncogene in Promoting Cancer Stem Cell-Like Characteristics in Osteosarcoma Cells

HMGB1 Promotes Cellular Proliferation and Invasion, Suppresses Cellular Apoptosis in Osteosarcoma

Deciphering possible mechanisms of action in pathophysiology of osteosarcoma: PI3K-Akt/MAPK pathways contribute to tumorigenesis versus FoxO/mTOR/HIF-1 pathways involved in metastasis.

Deciphering possible mechanisms of action in pathophysiology of osteosarcoma: PI3KAkt/MAPK pathways contribute to tumorigenesis versus FoxO/mTOR/HIF-1 pathways involved in metastasis.